Kindlin‑2 suppresses cervical cancer cell migration through AKT/mTOR‑mediated autophagy inductionGuangteng Wu(Guangxi Medical University), Desheng Yao(Guangxi Medical University)Oncology ReportsMay 4, 202010.3892/or.2020.7603Cited by 12SaveCiteExport RISWatch citationsRelated PapersAdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab plus tislelizumab and tislelizumab alone in patients with previously treated recurrent or metastatic cervical cancer|Gynecologic Oncology|2025|7Development and External Validation of a Novel Model for Predicting Postsurgical Recurrence and Overall Survival After Cytoreductive R0 Resection of Epithelial Ovarian Cancer|Frontiers in Oncology|2022|4